Related Experiment Video
Updated: Mar 13, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Relationship between Anemia and Serum Concentrations of Calcium and Phosphorus in Advanced Non-Dialysis-Dependent
Mauro Boronat1, Ángelo Santana, Elvira Bosch
1Section of Endocrinology and Nutrition, Hospital Universitario Insular, Las Palmas de Gran Canaria, Spain.
Insights
Anemia in advanced chronic kidney disease (CKD) is linked to mineral metabolism. Higher calcium and phosphorus levels are significantly associated with anemia in non-dialysis CKD patients.
Area of Science:
- Nephrology
- Bone Metabolism
- Anemia Pathophysiology
Background:
- Anemia of chronic kidney disease (CKD) is common, especially in dialysis patients.
- Biochemical abnormalities in metabolic bone disease are linked to anemia, but individual effects are unclear.
- This study focuses on advanced non-dialysis-dependent CKD patients.
Purpose of the Study:
- To assess the relationship between anemia and metabolic bone disease biomarkers.
- To investigate the individual impact of biomarkers on anemia development in advanced CKD.
- To analyze associations in a cohort of adult non-dialysis-dependent CKD patients.
Main Methods:
- 382 adult patients with advanced CKD were evaluated over 3 years.
- Logistic regression models analyzed associations between anemia and serum levels of calcium, phosphorus, PTH, 25(OH)D3, and alkaline phosphatase.
- Models were adjusted for demographic, clinical, and biochemical covariates.
Main Results:
- Serum calcium and phosphorus levels were significantly associated with anemia.
- Higher calcium and phosphorus levels correlated with lower and higher odds of anemia, respectively.
- Female sex and lower serum albumin were also independently associated with anemia.
Conclusions:
- Circulating calcium and phosphorus levels are strongly linked to anemia in advanced non-dialysis CKD.
- These mineral imbalances are key factors in the development of anemia in this patient group.
Background/Aims:
Different biochemical abnormalities of metabolic bone disease have been associated with anemia of chronic kidney disease (CKD), mainly in hemodialysis patients. However, all of these abnormalities are closely inter-related and their individual effect on the development of anemia is uncertain. This study was aimed to assess the relationship between anemia and a set of metabolic bone disease biomarkers in a cohort of adult patients with advanced non-dialysis-dependent CKD.
Methods:
The sample consisted of 382 patients submitted to a Nephrology Unit for evaluation of advanced CKD in a tertiary hospital from Gran Canaria during 3 years. Associations between anemia and serum levels of calcium (albumin-corrected), phosphorus, PTH, 25-hydroxivitamin D (25(OH)D3) and alkaline phosphatase were analyzed by using logistic regression models with adjustment for other demographic, clinical and biochemical covariates potentially related to anemia and to bone mineral metabolism.
Results:
Serum levels of calcium and 25(OH)D3 (negatively) and phosphorus (positively) were significantly associated with anemia in an unadjusted logistic regression model. In a fully adjusted multivariable model, the OR for anemia was 0.29 (95% CI 0.16-0.49; p < 0.0001) for every 1 mg/dl increase in serum calcium and 2.19 (95% CI 1.55-3.15; p < 0.001) for every 1 mg/dl increase in serum phosphorus. Female sex and lower serum albumin levels were also independently associated with anemia. The inclusion of albumin in the adjusted model displaced the significance of 25(OH)D3.
Conclusions:
Circulating levels of calcium and phosphorus are strongly linked to anemia in patients with advanced non-dialysis CKD.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Skeleton and Calcium Homeostasis
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily...
Peritoneal Dialysis III: Nursing Management
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

